Skip to main content
. Author manuscript; available in PMC: 2020 Jul 2.
Published in final edited form as: J Inherit Metab Dis. 2019 Jan;42(1):93–106. doi: 10.1002/jimd.12031

Table 1.

Variables, definitions and values

Variable Values (abbreviation)
Metabolic defect • ARG1-D, Arginase 1 deficiency
• ASL-D, Argininosuccinate lyase deficiency
• ASS-D, Argininosuccinate synthetase deficiency
• fOTC-D, female ornithine transcarbamylase deficiency
• mOTC-D, male ornithine transcarbamylase deficiency
• CITR-D, Citrin deficiency
• CPS1-D, Carbamylphosphate synthetase 1 deficiency ASx, asymptomatic
• HHH syndr., Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
• NAGS-D, N-Acetylglutamate synthase deficiency
Sex male/female
Mode of diagnosis • Prenatal testing (PT)
• Newborn screening (NBS)
• High-risk family screening (FH)
• Metabolic investigation after onset of symptoms (SX)
Ages and times • Age at diagnosis, if detected by PT set as zero (no prenatal UCD treatment)
• Age at first symptoms
• Age at last visit
• Diagnostic delay (age at diagnosis minus age at first symptoms; negative when diagnosed pre-symptomatically, positive when symptomatic before diagnosis)
• Observation period (time last visit minus time study inclusion)
Survival Yes/no
Changing from asymptomatic to symptomatic state Yes/no
Mode of confirmation of diagnosis • Enzyme analysis
• Metabolite analysis including amino acids
• Mutation analysis
• Pedigree analysis
Onset • Early onset (EO; ≤ 28 days)
• Late onset (LO; > 28 days)
• Asymptomatic (AS)
Symptomatic state Yes/no
E-IMD definition: showing clinical symptoms associated with the respective diagnosis
UCDC definition: symptoms associated with plasma ammonium concentrations > 100 μmol/L and/or liver transplant and/or ≥ 2 signs and symptoms: recurrent vomiting, protein intolerance, episodic lethargy, developmental and/or intellectual disabilities, abnormal neurological examination, brain edema on cranial MRI or CT scan, chronic migraine, and/or (episodic) psychosis
Signs and symptoms leading to the diagnosis unique to the E-IMD registry • Blood abnormalities
• Hyperexcitability
• Impaired consciousness
• Muscular hypertonia
• Muscular hypotonia
• Neurology other than seizures
• Seizures
• Sepsis-like appearance
• Vomiting and feeding problems

The following variables were used in UCDC and E-IMD for combined and comparative analysis between NA and EU.